|
|
CombiMatrix is supported by an executive team with experience building biotechnology and medical device companies. The team, which has expertise working with companies ranging from Fortune 500 leaders to start-up enterprises, brings to CombiMatrix broad vision, strategy, and experience developing and commercializing innovative healthcare technologies.
Our Executive Officers, as of September 2004, are as follows:
Amit Kumar, Ph.D.
Chief Executive Officer & President |
Dr. Kumar has been President and CEO since September 2001. He has been a Director since September 2000. Previously, Dr. Kumar was Vice President of Life Sciences of Acacia Research Corp. (NASDAQ: ACRI). From January 1999 to February 2000, Dr. Kumar was the founding President and Chief Executive Officer of Signature BioSciences, Inc., a life science company developing technology for advanced research in genomics, proteomics and drug discovery. From January 1998 to December 1999, Dr. Kumar was an Entrepreneur in Residence with Oak Investment Partners, a venture capital firm. From October 1996 to January 1998, Dr. Kumar was a Senior Manager at IDEXX Laboratories, Inc., a biotechnology company. From October 1993 to September 1996, Dr. Kumar was Head of Research & Development for Idetek Corporation, which was later acquired by Idexx Laboratories, Inc. Dr. Kumar received his bachelor's degree in chemistry from Occidental College. After joint studies at Stanford University and the California Institute of Technology, he received his Ph.D. from Caltech in 1991. He also completed a post-doctoral fellowship at Harvard University in 1993. |
Brooke Anderson, Ph.D.
Chief Operating Officer |
Brooke P. Anderson, Ph.D. has been Chief Operating Officer since February 2004. Previous positions at CombiMatrix include vice-presidential roles in engineering and software development, as well as serving as the company’s first president from October 1995 to January 1997. Prior to joining CombiMatrix, Dr. Anderson co-founded Acacia Research Corporation, and from January 1993 to August 1997, served as Acacia’s Vice President, Research and Development. Dr. Anderson received a B.S.E. in nuclear engineering from the University of Michigan in 1985, an M.S. in applied physics from the California Institute of Technology in 1987, and a Ph.D. in computation and neural systems from the California Institute of Technology in 1993. |
Scott Burell, CPA (Inactive)
Chief Financial Officer |
Scott Burell was promoted to Chief Financial Officer of CBMX in November 2006. Prior to this, Mr. Burell had served as our Vice President of Finance since November 2001 and as our Controller from February 2001 to November 2001. From May 1999 to first joining CombiMatrix in February 2001, Mr. Burell was the Controller for Network Commerce, Inc., a publicly traded technology and information infrastructure company located in Seattle. Prior to this, Mr. Burell spent 9 years with Arthur Andersen's Audit and Business Advisory practice in Seattle. Mr. Burell obtained his Washington state CPA license in 1992 and is a certified public accountant (currently inactive) and holds Bachelor of Science degrees in Accounting and Business Finance from Central Washington University. |
H. Sho Fuji
Vice President, Engineering & Production |
H. Sho Fuji has been Vice President of Engineering and Production since August 2004. Mr. Fuji has been with Combimatrix since October 2000 and held previous positions as Director of Microarray Technology and Manager of Wafer Development. Mr. Fuji had over 15 years of experience in the integrated circuit and MEMS fields before joining CombiMatrix, most recently as Laboratory Manager for the Washington Technology Center’s Microfabrication Laboratory from 1994 to 2000. He previously held management and process development positions at Materials Research Corporation, Boeing’s High Technology Center, and GAIN Semiconductor Corporation. Mr. Fuji received his B.S. in Materials Science and Engineering from MIT and a M.S. in Materials Science from Stanford University. |
Andy McShea, Ph. D.
Vice President, Biology & Chemistry |
Andy McShea has been with Combimatrix since 2000, serving as a Senior Scientist and then Business Development Manager. Dr. McShea has over 10 years of experience in the Life Sciences industry: ranging from drug discovery at Novartis and Bristol-Myers Squibb Pharmaceuticals to basic research at the Fred Hutchinson Cancer Research Center. Dr. McShea received his Ph.D. in 1996 studying transplantation immunology at Harvard Medical School and the University of Vienna, Austria. He also holds a B.Sc. in Cell Biology from the University of Wales, UK. |
|
ORDER 
